Identification of high-risk patients for adverse pregnancy outcome based on multivariate logistic regression analysis at 20-23 gestational weeks

Journal of Perinatal Medicine

Volumn 39, Issue 6, 2011, Pages 667-672

  Becker, Rolf ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Adverse pregnancy outcome; notch index; prediction

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; BIOMETRY; BODY MASS; CLINICAL EFFECTIVENESS; DISEASE SURVEILLANCE; DOPPLER ECHOGRAPHY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARITY; PATIENT IDENTIFICATION; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; UTERINE ARTERY;

ADOLESCENT; ADULT; ALGORITHMS; BODY MASS INDEX; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; MATERNAL AGE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; YOUNG ADULT;

EID: 80955140339     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.079     Document Type: Article

References (42)

1. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides K. Maternal serum placental growth factor at 11q0 to 13q6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:732-9.
2. Barton JR, Sibai BM. Prediction and prevention of recurrentpreeclampsia. Obstet Gynecol. 2008;112:359-72.
3. Becker R, Vonk R. Doppler sonography of uterine arteries at20-23 weeks: depth of notch gives information on probabilityof adverse pregnancy outcome and degree of fetal growth restriction in a low-risk population. Fetal Diagn Ther. 2010;27:78-86.
4. Becker R, Vonk R, Vollert W, Entezami M. Doppler sonography of uterine arteries at 20-23 weeks: risk assessment of adverse pregnancy outcome by quantification of impedance and notch. J Perinat Med. 2002;30:388-94.
5. Branch DW. The truth about inherited thrombophilias and pregnancy. Obstet Gynecol. 2010;115:2-4.
6. Campbell S, Pearce MF, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol. 1986;68:649-53.
7. Chiaffarino F, Parazzini F, Paladini D, Acaia B, Ossola W, Marozio L, et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;112:142-4.
8. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. Br J Obstet Gynaecol. 2006;113:580-9.
9. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP. The change in concentrations of angiogenic and antiangiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21:279-87.
10. Facco F, You W, Grobman W. Genetic thrombophilias and intrauterine growth restriction: a meta-analysis. Obstet Gynecol. 2009;113:1206-16.
11. Fonseca E, Yu CKH, Singh M, Papageorghiou AT, Nicolaides KH. Relationship between second-trimester uterine artery Doppler and spontaneous early preterm delivery. Ultrasound Obstet Gynecol. 2006;27:301-5.
12. Funai EF. Inherited thrombophilia and preeclampsia: is the evidence beginning to gongeal? Am J Obstet Gynecol. 2009;200:151.
13. Kahn SR, Platt RW, McNamara H, Rozen R, Goulet L, Seguin L. Inherited thrombophilia and preeclampsia: results of the Montreal preeclampsia study. Am J Obstet Gynecol. 2009;200;151:e1-9.
14. Kupferminc MJ. Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol. 2005;48:406-15.
15. Leduc L, Dubois E, Takser L, Rey E, David M. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can. 2007;29:787-93.
16. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45:86-91.
17. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, et al. Maternal-fetal flow, negative events, and preeclampsia. Hypertension. 2003;41:932-7.
18. Moldenhauer JS, Stanek J, Warschak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol. 2003;189:1173-7.
19. Muller PR, James AH, Murtha AP, Yonish B, Jamison MG, Dekker G. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester. Hypertens Pregnancy. 2006;25:183-92.
20. National collaborating centre for womens and childrens health. Commissioned by the National Institute for Health Clinical Excellence, London, UK. Antenatal care: routine care for the healthy pregnant woman. Clinical Guideline. London: RCOG Press; 2008.
21. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27:13-7.
22. Paidas M, Ku DH, Triche E, Lockwood C, Arkel Y. Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost. 2004;2:1194-5.
23. Palma-Dias RS, Fonseca MMC, Brietzke E, Fritsch A, Schlatter D, Marmann CB, et al. Screening for placental insufficiency by transvaginal uterine artery Doppler at 22-24 weeks of gestation. Fetal Diagn Ther. 2008;24:462-9.
24. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2007;19:103-9.
25. Pilalis A, Souka P, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks gestation. Ultrasound Obstet Gynecol. 2007; 29:135-40.
26. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11q0 to 13q6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007; 30:742-9.
27. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24:104-10.
28. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53:812-8.
29. Poon LCY, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol. 2009;34:142-8.
30. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PIGF) in small for gestational age pregnancy at 11(q0) to 13(q6) weeks of gestation. Prenat Diagn. 2008;28:1110-5.
31. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomised controlled trial. J Thromb Haemost. 2009;7:58-64.
32. Rodger MA, Paidas M, Claire McL, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol. 2008;112:320-4.
33. Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010;115:5-13.
34. Sebire NJ, Goldin RD, Regan I. Term pre-eclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol. 2005;25: 117-8.
35. Simonazzi G, Vicenzi C, Rizzo MA, Farina A, Gabrielli S, Arcelli D, et al. Prospective evaluation of the risk of preeclampsia using logistic regression analysis. Ultrasound Obstet Gynecol. 2007;30:312-7.
36. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimesteruterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynecol. 2007;29:128-34.
37. Stepan H, Faber R, Wesel N, Wallukat G, Schultheiss H-P, Walther T. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab. 2006;91:2424-7.
38. Thangaratinam S, Langenveld J, Mol BW, Khan KS. Prediction and primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;29:419-33.
39. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol. 2001;184:1267-72.
40. Torricelli M, Reis FM, Florio P, Severi FM, Bocchi C, Picciolini E, et al. Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension. Ultrasound Med Biol. 2006;32: 1431-5.
41. Voigt M, Schneider KTM, Jaehrig K. Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland. Geburtsh. U. Frauenheilk. 1996;56:550-8.
42. Yu CKH, Smith GCS, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk-women. Am J Obstet Gynecol. 2005;193:429-36.